Composition:

Each tablet contains 5mg Selegiline Hydrochloride.

INDICATION:

Used to treat primarily Parkinson disease and can be separately use to indicate non-aged Parkinson disease or as an adjunct in the management of Parkinsonian patients being treated with Levodopa/carvidopa who exhibit deterioration in the quality of their response of this therapy.

Combine with levodopa for the movement fluctuates.

DOSAGE AND ADMINISTRATION:

Oral taking, the beginning dosage is morning time one tablet ( 5mg). Selegiline dosage can be increased to two tablets (10mg ） per day. (on the morning to take the two tablets or take one each in morning and noon). If the patients get the adverse reaction for taking levodopa or combining with taking levodopa,

PACKING & SHELF LIFE:

Packing is 5mg× 10’ s and shelf life is 2 years from date of manufacture.